Analytical Data
-
基因名
GRA2
- Application
-
别名
28 kDa antigen GP28.5
-
种属
Toxoplasma gondii
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P13404
-
表达区间
24-185aa
-
分子量
25.0 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GRA2, or Glycosylated Protein Related to Adhesion 2, is a vital protein found in various organisms, particularly in the context of pathogens and host interactions. Its study is primarily driven by its significant role in cellular adhesion, immune evasion, and pathogenicity. Research surrounding GRA2 is pivotal for understanding its molecular mechanisms, structure-function relationships, and potential impacts on host immune responses. In particular, GRA2 is known to be involved in the life cycle of Toxoplasma gondii, a crucial protozoan parasite that poses serious health risks to immunocompromised individuals and pregnant women. As GRA2 has been implicated in the modulation of host cell processes, its investigation is essential for developing novel therapeutic approaches aimed at mitigating the effects of T. gondii infection. Additionally, GRA2’s properties as a recombinant protein have garnered interest in vaccine research, where it could potentially serve as an antigen for eliciting robust immune responses. The exploration of GRA2 not only enhances our understanding of its biological functions but also opens pathways for innovative strategies in infectious disease control and management, making it a prominent focus within molecular biology and infectious disease research.












